Moderna Names Juan Andres Chief Operating Officer as Jerh Collins Retires
Article excerpt
Highlighted: the sentence this signal was extracted from
Moderna has named Juan Andres Chief Operating Officer, bringing the longtime manufacturing executive back to the company in a newly created role as the biotechnology company prepares for potential expansion in oncology and scales a broader portfolio of commercial vaccines. Andres will return to Moderna effective Oct. 5, 2026, reporting to CEO Stéphane Bancel and joining the company's Executive Committee. He will work across Moderna on operational priorities and execution while directly leading its manufacturing organization. The company also announced that Jerh Collins, Ph.D., Chief Technical Operations and Quality Officer, will retire following four years at Moderna. Creating the COO position comes as Moderna's operating requirements become more diverse. The company is preparing for the potential launch and manufacturing scale-up of intismeran autogene following positive Phase 3 results, while continuing to develop a broader oncology portfolio. Its infectious disease business has also expanded to five approved vaccines following the recent U.S. Food and Drug Administration approval of Moderna's seasonal influenza vaccine and European Commission marketing authorization of its seasonal flu and COVID combination vaccine. Those developments increase the importance of coordinating manufacturing, portfolio priorities and execution across businesses with different production and...
Keep reading with a free account
The rest of this article, and every signal for Moderna, is in your free account.
